Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,876 total articles

Hims & Hers Health CLO Executes $283,890 Stock Sale Amid Shifting Regulatory and Competitive Landscape

Hims & Hers Health CLO Executes $283,890 Stock Sale Amid Shifting Regulatory and Competitive Landscape

Soleil Boughton, the Chief Legal Officer at Hims & Hers Health, Inc. (NYSE:HIMS), has completed a sale of her company's Class A Common Stock. The transaction, which totaled $283,890, was finalized on April 20, 2026. This divestment was carried out through a Rule 10b5-1 trading plan that Boughton had established on November 18, 2025.The sale involve…

Hims & Hers CFO Executes Structured Stock Sale and Option Exercises

Hims & Hers CFO Executes Structured Stock Sale and Option Exercises

Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. (NASDAQ:HIMS), has completed a series of transactions involving company stock. On April 20, 2026, Mr. Okupe sold 19,645 shares of Class A Common Stock, resulting in a total transaction value of $588,615. These sales were conducted at a weighted average price of $29.9626 per shar…

Quantum-Si CEO Executes Mandatory Tax-Related Share Sales

Quantum-Si CEO Executes Mandatory Tax-Related Share Sales

Jeffrey Alan Hawkins, the President and Chief Executive Officer of Quantum-Si Inc (NASDAQ: QSI), has completed the sale of 167,424 shares of Class A Common Stock. The transactions, which occurred over two days in April 2026, resulted in a total liquidation value of approximately $167,541. These disposals were not discretionary market sales but were…

BioCardia CEO Executes Strategic Stock Purchases Amid Regulatory Progress and Clinical Developments

BioCardia CEO Executes Strategic Stock Purchases Amid Regulatory Progress and Clinical Developments

BioCardia, Inc. (NASDAQ:BCDA) President and Chief Executive Officer Peter Altman has completed a series of personal share acquisitions. The transactions, totaling $1,230, were documented in a Form 4 filing submitted to the Securities and Exchange Commission on April 22, 2026. These purchases occurred over a two-day period spanning April 20 and Apri…

Finance of America CIO Executes Rule 10b5-1 Stock Sale

Finance of America CIO Executes Rule 10b5-1 Stock Sale

Jeremy Prahm, the Chief Investment Officer for Finance of America Companies Inc. (NYSE: FOA), has completed a sale of company stock. The transaction involved 6,000 shares of Class A Common Stock, totaling $138,048. This divestment occurred on April 20, 2026, following a predetermined trading plan established in late 2025.